Highlight
Successful together – our valantic Team.
Meet the people who bring passion and accountability to driving success at valantic.
Get to know us
Newly defined SRM model
Strategic risk concept for Vetter Pharma
Together with valantic, Vetter Pharma designed a supplier risk management model based on proven best practices. A structured GAP analysis, benchmarking and clearly defined responsibilities increased the resilience of the supply chain.
About the company
Vetter Pharma is a German Contract Manufacturing Organization (CMO) for pharmaceutical products. The company employs over 5,700 people and has an annual turnover of more than 840 million euros. Together with valantic, a future-oriented Supplier Risk Management (SRM) was developed. The aim was to develop a resilient and efficient SRM model based on external sources, benchmarking and best practices – tailored to current industry and customer requirements.
The project
The challenge
As a result of global crises, pandemics and natural disasters, the resilience of the supply chain also came into focus at Vetter Pharma. The existing SRM process was no longer sufficiently aligned with customer needs and market developments. Further development was necessary in order to counter potential risks at an early stage and to meet regulatory requirements. It was also intended to help the company position itself strategically in the market.
Consulting approach
1. Analysis of the current state and GAP analysis
- Investigation of existing risks, data structures and product portfolios
- Conducting best practice interviews and SRM benchmarking
- Systematic GAP analysis along all relevant SRM dimensions
- Moderation of coordination workshops for requirements validation
2. Design of a holistic SRM model
- Development of efficient operating models for managing supplier risks
- Integration of internal and external KPIs for risk assessment
- Definition of preventive and reactive action plans
- Design of clear roles, responsibilities and communication channels
Solutions & results in detail
A supplier risk management model based on international best practices was developed jointly. It integrates external data sources, clear responsibilities and comprehensive reporting. Training for purchasing managers ensures effective application in day-to-day business.
Conclusion
Vetter Pharma strengthened its risk management along the supply chain with valantic. The new system creates transparency, increases responsiveness and makes the company more resilient to market fluctuations.
